XTL BIOPHARMACEUTICALS LTD's ticker is XTLB and the CUSIP is 98386D307. A total of 4 filers reported holding XTL BIOPHARMACEUTICALS LTD in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Noked Capital LTD | 198,888 | $871,000 | 0.20% |
| Noked Israel Ltd | 198,888 | $871,000 | 0.20% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 51,671 | $226,000 | 0.00% |
| Citadel Advisors | 12,801 | $56,000 | 0.00% |
| Renaissance Technologies | 22,280 | $98,000 | 0.00% |
| UBS Group AG | 2,898 | $13,000 | 0.00% |